Gloucestershire Hospitals NHS Foundation Trust

Specialist MDT: Gloucestershire Hospitals NHS Foundation Trust

View Provider Services

The following services are available at this hospital trust (updated 2021). Men diagnosed at this trust may be able to access additional services from other trusts within the specialist multidisciplinary team:

  • Diagnostic Facilities:
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Whole body MRI
    • Isotope bone scan
  • Treatment Facilities:
    • Radical prostatectomy
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy (EBRT)
    • Chemotherapy
    • Clinical trials unit
  • Support Service Facilities:
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services
    • Specialist continence services
    • Psychological counselling
    • Genetic counselling

Data Quality

For these results, data for England were provided for 1st April 2019 to 31st March 2020 from the Rapid Cancer Registration Dataset (RCRD), which is sourced mainly from the Cancer Services and Outcomes Dataset (COSD) containing proxy tumour registrations, as the standard Cancer Registration data were unavailable. More details can be found here.

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 648 889
Performance Status recorded 1% 25%
TNM completed 57% 52%
Stage variable assigned 60% 57%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 291 34801
Percentage of men diagnosed with metastatic disease 14% 13%

Management

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on PSA and Gleason score in the Rapid Cancer Registration Dataset

Outcome

Treatment Centre
No. of men who received radical prostatectomy (2019-2020) 159
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 9%
No. of men who received radical prostatectomy (2018) 75
Adjusted percentage of men experiencing at least one GU complication (%) 8%
No. of men who received radical radiotherapy (2018) 99
Adjusted percentage of men receiving a procedure of the large bowel and a diagnosis indicating radiation toxicity (GI complication) (%) 10%

Compare provider outcomes